Stocks St. Jude Medical Inc

More

  • The Lightning Round is extended in this CNBC.com exclusive feature.

  • Hint: The real story in the sector has nothing to do with President Obama.

  • Boston Scientific has rallied back to its highest levels since last year's financial crisis and is scheduled to discuss a key defibrillator trial this morning, prompting one large investor to position for a potential decline.

  • The Dow and S&P snapped their winning streaks Wednesday as disappointing earnings from two of Wall Street's biggest names overshadowed another round of earnings beats.

  • Stocks wobbled Wednesday as a slew of earnings beats, including one from Pfizer, were encouraging but disappointing reports from two of Wall Street's biggest names dragged on the market.

  • Stocks wobbled Wednesday as a slew of earnings beats, including one from Pfizer, were encouraging but disappointing reports from two of Wall Street's biggest names dragged on the market.

  • Futures indicated a lower open for Wall Street Wednesday as cautious words from Federal Reserve Chairman Ben Bernanke and Yahoo's missing revenue expectations lent to investors taking profits.

  • This sector offers long-term growth, even in a slowdown. Even oil can’t promise that.

  • graphic_word_ofthe_street.jpg

    The market traded sideways on Tuesday with Dow finishing slightly lower and the S&P 500 closing a little higher.

  • Russia's RTS Index was the first global index to hit the correction stage (down 23 percent since hitting its recent high on June 2nd), but now the MSCI Emerging Markets Index (EEM in its ETF form) is also down double-digits since hitting its recent high on June 1st.

  • boston_scientific.jpg

    This takes the prize for the most dangerously optimistic acronym for a clinical trial. But MADIT (pronounced "made it") made it. Some folks with a lot of chutzpah at Guidant, now owned by Boston Scientific, apparently came up with the name for their big studies on implantable cardio defibrillators.

  • Cramer makes the call on viewers' favorite stocks.

  • The president’s budget changes sent stocks tumbling, some undeservedly so.

  • Amid the gloom, Birinyi Associates' Cleve Rueckert found what he sees as a bright spot in the stock market. In a note, he says growth is the place to be, based on performance of the S&P's Pure Growth Index versus the S&P Pure Value Index. Here's his list of 15 stocks in the S&P 500 that fit three key growth criteria.

  • This company has heart, Cramer says. Find out how BSX fought its way off the operating table.

  • It’s easy to like a company that, even in this environment, is focused on taking share.

  • Intuitive Surgical, a California company that makes endoscopic instruments, is running higher along with heavy options activity amid takeover rumors.

  • Following are the day’s biggest winners and losers. Find out why shares of Texas Instruments and Hershey popped while Valero and McGraw-Hill dropped.

  • Boston Scientific is fighting to break out of its recent trading range as a large block of puts changes hands. BSX opened today by more than 2 percent from its close of $7.60 yesterday... The put activity coincides with a company setback in its protracted court battle with Johnson & Johnson.

  • To give investors an edge, CNBC asked the experts for their best trades now.